TY  - JOUR
T1  - FOrecasting age-related macular degeneration through 2050
AU  - Klein BK, Klein R
Y1  - 2009/05/27
N1  - 10.1001/jama.2009.729
JO  - JAMA
SP  - 2152
EP  - 2153
VL  - 301
IS  - 20
N2  - 
Age-related macular degeneration (AMD) is an insidious process that increases in prevalence and severity predictably with age. The end stage of this condition causes profound loss of central vision. In the Beaver Dam Eye Study, in persons who were aged 75 years or older, the 15-year cumulative incidence of early stage AMD in the more severely involved eye was 24% and of late stage AMD it was 8%.1 In that study, more than 52% of eyes with incident severe loss of vision (20/200 or poorer) had late-stage AMD.2

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.729
UR  - http://dx.doi.org/10.1001/jama.2009.729
ER  -